Evaluation and treatment of anxiety symptoms and disorders in alcoholics

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 7, 1996, Pages 15-22

  Kranzler, Henry R ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANXIETY NEUROSIS; DRINKING BEHAVIOR; HUMAN; PRIORITY JOURNAL; REVIEW;

ALCOHOL DRINKING; ALCOHOLISM; ANTI-ANXIETY AGENTS; ANXIETY; ANXIETY DISORDERS; BUSPIRONE; CLINICAL TRIALS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; PREVALENCE; RECURRENCE; SEVERITY OF ILLNESS INDEX; TEMPERANCE; TREATMENT OUTCOME;

EID: 0029737932     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Helzer J, Pryzbeck T. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 1988;49:210-224
2. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985;42:1050-1055
3. Ross H, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988;44:1023-1031
4. Khantzian E. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-1264
5. Vaillant G. The National History of Alcoholism. Cambridge, Mass: Harvard University Press; 1983
6. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990;147:685-695
7. Schuckit MA, Hesselbrock V. Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 1994;151:1723-1734
8. Nathan PE, O'Brien JS. An experimental analysis of the behavior of alcoholics and nonalcoholics during prolonged experimental drinking: a necessary precursor of behavior therapy? Behavior Therapy 1971;2:455-476
9. George DT, Nutt DJ, Dwyer BA, et al. Alcoholism and panic disorder: is the comorbidity more than coincidence? Acta Psychiatr Scand 1990;81:97-107
10. Brown SA, Irwin M, Schuckit MA. Changes in anxiety among abstinent male alcoholics. J Stud Alcohol 1991;52:55-61
11. Bibb JL, Chambless CL. Alcohol use and abuse among diagnosed agoraphobics. Behav Res Ther 1986;24:49-58
12. Pickens RW, Hatsukami DK, Spicer JW, et al. Relapse by alcohol abusers. Alcohol Clin Exp Res 1985;9:244-247
13. Quitkin FW, Rifkin A, Kaplan J, et al. Phobic anxiety syndrome complicated by drug dependence and addiction: a treatable form of drug abuse. Arch Gen Psychiatry 1972;27:154-162
14. Kranzler HR, Liebowitz N. Anxiety and depression in substance abuse: clinical implications. In: Frazier S, ed. Anxiety and Depression, Medical Clinics of North America. Philadelphia, Pa: Williams & Wilkins; 1988; 72:867-885
15. Meyer RE. Anxiolytics and the alcoholic patient. J Stud Alcohol 1986; 47:269-273
16. Goodwin DW, Guze SB. Psychiatric Diagnosis. New York, NY: Oxford University Press; 1980
17. Schuckit M. The clinical implications of primary diagnostic groups among alcoholics. Arch Gen Psychiatry 1985;42:1043-1049
18. Kadden RM, Kranzler HR, Rounsaville BJ. Validity of the distinction between "substance-induced" and "independent" depression and anxiety disorders. American Journal on Addictions 1995;4:107-117
19. Thevos AK, Johnston AL, Latham PK, et al. Symptoms of anxiety in inpatient alcoholics with and without DSM-III-R anxiety diagnoses. Alcohol Clin Exp Res 1991;15:102-105
20. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
21. Sheehan DV. The Anxiety Disease. New York, NY: Scribner; 1983
22. Mayfield DG. Alcohol and affect: experimental studies. In: Goodwin DW, Erickson CK, eds. Alcoholism and Affective Disorders: Clinical, Genetic and Biochemical Studies. New York, NY: Spectrum Publications; 1979: 99-107
23. McNamee HB, Mello NK, Mendelson JH. Experimental analysis of drinking patterns of alcoholics: concurrent psychiatric observations. Am J Psychiatry 1968;124:1063-1069
24. Tamerin JS, Mendelson JH. The psychodynamics of chronic inebriation: observations of alcoholics during the process of drinking in an experimental group setting. Am J Psychiatry 1969;125:886-899
25. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologie Catchment Area (ECA) study. JAMA 1990;264:2511-2518
26. Mullaney JA, Trippett CJ. Alcohol dependence and phobias: clinical description and relevance. Br J Psychiatry 1979;135:565-573
27. Bowen RC, Cipywnyk D, D'Arcy C, et al. Alcoholism, anxiety disorders, and agoraphobia. Alcohol Clin Exp Res 1984;8:48-50
28. Smail P, Stockwell T, Canter S, et al. Alcohol dependence and phobic anxiety states, I: a prevalence study. Br J Psychiatry 1984;144:53-57
29. Woodruff RA, Guze SB, Clayton PJ. Anxiety neurosis among psychiatric outpatients. Compr Psychiatry 1972;13:165-170
30. Kissin B. The use of psychoactive drugs in the long-term treatment of chronic alcoholics. Ann N Y Acad Sci 1975;252:385-395
31. Ciraulo DA, Barnhill JG, Greenblatt DJ, et al. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry 1988; 49:333-337
32. Jaffe JH, Kranzler HR, Ciraulo DA. Drags used in the treatment of alcoholism. In: Mendelson J, Mello N, eds. Medical Diagnosis and Treatment of Alcoholism. New York, NY: McGraw-Hill; 1992:421-461
33. Roy-Byrne PP, Katon W. An update on treatment of the anxiety disorders. Hosp Community Psychiatry 1987;8:835-843
34. Ballenger JC, Burrows GD, DuPont RL, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Arch Gen Psychiatry 1988;45:413-422
35. Ciraulo DA, Alderson LM, Chapron DJ, et al. Imipramine disposition in alcoholics. J Clin Psychopharmacol 1982;2:2-7
36. American Psychiatric Association. Tricyclic antidepressants-blood level measurements and clinical outcome: an APA Task Force Report. Am J Psychiatry 1985;142:155
37. Schottenfeld RS, O'Malley SS, Smith L, et al. Clinical note: limitation and potential hazards of MAOIs for the treatment of depressive symptoms in abstinent alcoholics. Am J Drug Alcohol Abuse 1989;15:339-344
38. Jaffe JH, Ciraulo DA, Nies A, et al. Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal. Clin Pharmacol Ther 1983;34:623-630
39. Griffiths RR, McLeod DR, Bigelow GE, et al. Comparison of diazepam and oxazepam: preference, liking and extent of abuse. J Pharmacol Exp Ther 1984;229:501-508
40. Taylor DP, Eison MS, Riblet LA, et al. Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 1985;23:687-694
41. Mattila MJ, Aranko K, Seppala T. Acute effects of buspirone and alcohol on psychomotor skills. J Clin Psychiatry 1982;43(12, sec 2):56-60
42. Seppala T, Aranko K, Mattila MJ, et al. Effects of alcohol on buspirone and lorazepam actions. Clin Pharmacol Ther 1982;32:201-207
43. Balster RL. Abuse potential of buspirone and related drugs. J Clin Psychopharmacol 1990;10:31S-37S
44. Cole JO, Orzack MH, Beake B, et al. Assessment of the abuse liability of buspirone in recreational sedative users. J Clin Psychiatry 1982;43(12, sec 2):69-74
45. Griffith JD, Jasinski DR, Casten GP, et al. Investigation of the abuse liability of buspirone in alcohol-dependent patients. Am J Med 1986;80(suppl 3B):30-35
46. Naranjo CA, Sellers EM, Lawrin MO. Modulation of ethanol intake by serotonin uptake inhibitors. J Clin Psychiatry 1986:47(4, suppl): 16-22
47. 1A receptor agonists on ethanol preference in the rat. Alcohol 1992;9:283-286
48. Privette TH, Hornsby RI, Myers RD. Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol 1988;5:147-152
49. Collins DM, Myers RD. Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol 1987;4:49-56
50. Svensson L, Fahlke C, Hard E, et al. Involvement of the serotonergic system in ethanol intake in the rat. Alcohol 1993;10:219-224
51. 1A agonist gepirone on alcohol intake in the rat during restricted access. Presented at the Fifth Congress of the International Society for Biomedical Research on Alcoholism; June 17-22, 1990; Toronto, Canada
52. Kranzler HR, Meyer RE. Open trial of buspirone in alcoholics. J Clin Psychopharmacol 1989;9:379-380
53. Olivera AA, Sarvis S, Heard C. Anxiety disorders coexisting with substance dependence: treatment with buspirone. Curr Ther Res 1990;47: 52-61
54. Bruno F. Buspirone in the treatment of alcoholic patients. Psychopathology 1989;22(suppl):49-59
55. Tollefson GD, Montague-Clouse J, Tollefson SL. Treatment of comorbid generalized anxiety in a recently detoxified alcohol population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 1992;12: 19-26
56. Kranzler HR, Burleson JA, Del Boca FK, et al. Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry 1994;51:720-731
57. Riblet LA, Taylor DP, Eison MS, et al. Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 1982;43(12, sec 2):11-16
58. Malcolm R, Anton RF, Randall CL, et al. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 1992;16: 1007-1013
59. Marlatt GA. Relapse prevention: theoretical rationale and overview of the model. In: Marlatt GA, Gordon JR, eds. Relapse Prevention. New York, NY: Guilford Press; 1985:3-70
60. Edwards G, Gross MM. Alcohol dependence: provisional description of a clinical syndrome. BMJ 1976;1:1058-1061